About our company.
Darou Teb Rastak (DTR) is a pharmaceutical company which has been registered in Iran. DTR is to support rare disease patients when it comes to their needed drugs. DTR is in direct contact with suppliers all around the world in order to meet rare disease patients’ needs.
DTR is relatively working with Rare Disease Foundation of Iran. The Foundation indicates the demand and market needs to DTR and thereafter DTR place the orders to suppliers abroad and perform the commercial tasks accordingly.
Elosulfase alfa (trade name Vimizim) is a drug for the treatment of Morquio syndrome which is caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase. Elosulfase alfa is a synthetic version of this enzyme.
Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy, a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder.